We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Donaldson (DCI) Invests in 25,000 Square-Foot Technical Center
Read MoreHide Full Article
Donaldson Company, Inc. (DCI - Free Report) has announced that it plans to develop a 25,000 square-foot life sciences technical center at 5 Lab Drive in Research Triangle Park (RTP) to expand its life sciences portfolio.
Donaldson’s technical center is currently situated at a campus that supports budding biotechnology firms. The campus also has state-of-the-art laboratories and cleanrooms that provide product manufacturing capacity. The company’s brands like Isolere Bio, Purilogics, Solaris Biotech and Univercells Technologies are either located or under development at this facility. The bioprocessing solutions will be designed, developed and unveiled at the facility. The technical facility will also provide support in the early commercialization of transformational bioprocessing solutions.
This expansion positions DCI to develop and commercialize the IsoTag reagent product line. The expanded facility at RTP will assist the customers in their research through clinical and commercial-scale activities.
In the quarters ahead, Donaldson is expected to benefit from its strong product portfolio, solid demand, focus on innovation and growth investments in the Life Sciences segment. A diversified business structure with exposure in various geographies and end markets like construction, mining, aerospace, defense, and food & beverage is a boon for the company.
Zacks Rank & Stocks to Consider
Donaldson currently carries a Zacks Rank #4 (Sell). Some better-ranked companies from the Industrial Products sector are discussed below:
In the past 60 days, estimates for Graco’s 2023 earnings have increased 1.7%. The stock has gained 12.2% in the past year.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank of 2 and a trailing four-quarter earnings surprise of 13.9%, on average.
AIT’s earnings estimates have increased 1.9% for fiscal 2024 (ending June 2024) in the past 60 days. Shares of Applied Industrial have risen 28.4% in the past year.
A. O. Smith Corporation (AOS - Free Report) currently carries a Zacks Rank of 2. The company delivered a trailing four-quarter earnings surprise of approximately 14%, on average.
In the past 60 days, estimates for A. O. Smith’s earnings have increased 4.5% for 2023. The stock has soared 22.3% in the past year.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Donaldson (DCI) Invests in 25,000 Square-Foot Technical Center
Donaldson Company, Inc. (DCI - Free Report) has announced that it plans to develop a 25,000 square-foot life sciences technical center at 5 Lab Drive in Research Triangle Park (RTP) to expand its life sciences portfolio.
Donaldson’s technical center is currently situated at a campus that supports budding biotechnology firms. The campus also has state-of-the-art laboratories and cleanrooms that provide product manufacturing capacity. The company’s brands like Isolere Bio, Purilogics, Solaris Biotech and Univercells Technologies are either located or under development at this facility. The bioprocessing solutions will be designed, developed and unveiled at the facility. The technical facility will also provide support in the early commercialization of transformational bioprocessing solutions.
This expansion positions DCI to develop and commercialize the IsoTag reagent product line. The expanded facility at RTP will assist the customers in their research through clinical and commercial-scale activities.
Donaldson Company, Inc. Price
Donaldson Company, Inc. price | Donaldson Company, Inc. Quote
In the quarters ahead, Donaldson is expected to benefit from its strong product portfolio, solid demand, focus on innovation and growth investments in the Life Sciences segment. A diversified business structure with exposure in various geographies and end markets like construction, mining, aerospace, defense, and food & beverage is a boon for the company.
Zacks Rank & Stocks to Consider
Donaldson currently carries a Zacks Rank #4 (Sell). Some better-ranked companies from the Industrial Products sector are discussed below:
Graco Inc. (GGG - Free Report) presently carries a Zacks Rank #2 (Buy). GGG’s earnings surprise in the last four quarters was 7.2%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
In the past 60 days, estimates for Graco’s 2023 earnings have increased 1.7%. The stock has gained 12.2% in the past year.
Applied Industrial Technologies, Inc. (AIT - Free Report) presently carries a Zacks Rank of 2 and a trailing four-quarter earnings surprise of 13.9%, on average.
AIT’s earnings estimates have increased 1.9% for fiscal 2024 (ending June 2024) in the past 60 days. Shares of Applied Industrial have risen 28.4% in the past year.
A. O. Smith Corporation (AOS - Free Report) currently carries a Zacks Rank of 2. The company delivered a trailing four-quarter earnings surprise of approximately 14%, on average.
In the past 60 days, estimates for A. O. Smith’s earnings have increased 4.5% for 2023. The stock has soared 22.3% in the past year.